[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Enteral Feeding Formula Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026

October 2018 | 100 pages | ID: E2C93700CAAEN
Data Bridge Market Research

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Europe enteral feeding formula market is expected to reach at a CAGR of 6.1% in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Product (Standard Formulas, Disease Specific), Application (Critical Care, Gastroenterology, Oncology, Neurology, Diabetes, Others), Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrotomy Tube Feeding, Duodenal or Jejunal Tube Feeding), Stage (Adult, Pediatric), End User (Hospitals, Long Term Care Facilities), Country (Germany, U.K., France, Spain, Italy, Switzerland, Netherlands, Norway, Belgium, Russia, Poland, Turkey and Rest of Europe)

Major growing sectors under the Market Segmentation are as follows:
  • In product, the standard formulas segment is dominating the enteral feeding formula market as the standard formula is rapidly growing in the industry due to its medical application also the composition of the standard formulas are rich in the vitamins, proteins, peptides, which is mostly preferred amongst population for better health and also in the diet concern population.
  • In application, the critical care segment is dominating the market critical care segment due to rapidly growth in the enteral feeding formula industry due to the rising number of the patients from the chronic disease, which also leading the consumption of nutritional feeding formulas more towards the patients with the ventilators.
  • In type of tube feeding, the gastric tube feeding is dominating the market; the gastric tube feeding segment is rising in the forecast period due to the rising eating disorder in the various reasons leading the bypass route nutritional supplies and with the effortless and painless supply of the nutrients by the gastric route.
  • In stage, the adult segment in the enteral feeding formula market is growing with the highest share and dominating the market due to the growing lifestyle concern and changing diet plans and rising awareness towards the fitness also due to the rising prevalence of chronic diseases amongst adult generation.
  • In end user, hospitals are the institutes which are highly preferred by the patients for diagnosis and treatment. The technology is advanced and offers high precise results in the affordable prices which can be done in hospitals than diagnostic centers and specialty clinics.
Key Market Players

The Key Market Players for Europe enteral feeding formula market are listed below:
  • Abbott
  • Nestle
  • Meiji Holdings CO., LTD
  • B. Braun Melsungen AG
  • Danone Nutricia
  • Fresenius SE & CO. KGAA
  • Global Health Products, Inc
  • Hormel Foods, Llc
  • Mead Johnson & Company, Llc
  • Medline Industries, Inc
  • Medtrition, Inc
  • Nutritional Medicinals, Llc
  • Real Food Blends
  • Victus
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE ENTERAL FEEDING FORMULA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS
  3.1.1 RISING NUMBER OF PRETERM BIRTH
  3.1.2 GROWING NUMBER OF CHRONIC DISEASES
  3.1.3 GROWING BUSINESS EXPANSION FOR NUTRITIONAL SUPPLY
  3.1.4 GROWING NEED OF NUTRITIONAL CARE FOR GERIATRIC POPULATION
3.2 RESTRAINTS
  3.2.1 RISK ASSOCIATED WITH THE ENTERAL TUBE FEEDING
  3.2.2 STRICT REGULATION OF USAGE FOR PATIENTS SAFETY
3.3 OPPORTUNITIES
  3.3.1 GROWTH IN HEALTHCARE EXPENDITURE OF DEVELOPING ECONOMIES
3.4 CHALLENGES
  3.4.1 INSUFFICIENT REIMBURSEMENTS POLICIES
  3.4.2 LACK OF TRAINED STAFF

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE ENTERAL FEEDING FORMULA MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 STANDARD FORMULAS
  6.2.1 MONOMERIC
  6.2.2 POLYMERIC
6.3 DISEASE SPECIFIC
  6.3.1 DIABETIC FORMULAS
  6.3.2 RENAL FORMULAS
  6.3.3 HEPATIC FORMULAS
  6.3.4 PULMONARY FORMULAS
  6.3.5 OTHERS

7 EUROPE ENTERAL FEEDING FORMULA MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 CRITICAL CARE
7.3 GASTROENTEROLOGY
7.4 ONCOLOGY
7.5 NEUROLOGY
7.6 DIABETES
7.7 OTHERS

8 EUROPE ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING

8.1 OVERVIEW
8.2 GASTRIC TUBE FEEDING
8.3 NASOGASTRIC TUBE FEEDING
8.4 GASTROTOMY TUBE FEEDING
8.5 DUODENAL OR JEJUNAL TUBE FEEDING

9 EUROPE ENTERAL FEEDING FORMULA MARKET, BY STAGE

9.1 OVERVIEW
9.2 ADULT
9.3 PEDIATRIC

10 EUROPE ENTERAL FEEDING FORMULA MARKET, BY END USER

10.1 OVERVIEW
10.2 HOSPITALS
10.3 LONG TERM CARE FACILITIES
  10.3.1 HOME CARE AGENCIES AND HOSPICES
  10.3.2 NURSING HOMES
  10.3.3 ASSISTED LIVING FACILITIES

11 EUROPE ENTERAL FEEDING FORMULA MARKET, BY GEOGRAPHY

11.1 EUROPE
  11.1.1 GERMANY
  11.1.2 U.K.
  11.1.3 FRANCE
  11.1.4 SPAIN
  11.1.5 ITALY
  11.1.6 SWITZERLAND
  11.1.7 NETHERLAND
  11.1.8 NORWAY
  11.1.9 BELGIUM
  11.1.10 RUSSIA
  11.1.11 POLAND
  11.1.12 TURKEY
  11.1.13 REST OF EUROPE

12 EUROPE ENTERAL FEEDING FORMULA MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 COMPANY PROFILE

13.1 ABBOTT
  13.1.1 COMPANY SNAPSHOT
  13.1.2 REVENUE ANALYSIS
  13.1.3 COMPANY SHARE ANALYSIS
  13.1.4 PRODUCT PORTFOLIO
  13.1.5 RECENT DEVELOPMENTS
13.2 NESTLÉ
  13.2.1 COMPANY OVERVIEW
  13.2.2 REVENUE ANALYSIS
  13.2.3 COMPANY SHARE ANALYSIS
  13.2.4 PRODUCT PORTFOLIO
  13.2.5 RECENT DEVELOPMENTS
13.3 MEIJI HOLDINGS CO., LTD.
  13.3.1 COMPANY OVERVIEW
  13.3.2 REVENUE ANALYSIS
  13.3.3 COMPANY SHARE ANALYSIS
  13.3.4 PRODUCT PORTFOLIO
  13.3.5 RECENT DEVELOPMENTS
13.4 B. BRAUN MELSUNGEN AG
  13.4.1 COMPANY SNAPSHOT
  13.4.2 REVENUE ANALYSIS
  13.4.3 COMPANY SHARE ANALYSIS
  13.4.4 PRODUCT PORTFOLIO
  13.4.5 RECENT DEVELOPMENTS
13.5 DANONE NUTRICIA
  13.5.1 COMPANY SNAPSHOT
  13.5.2 GEOGRAPHICAL PRESENCE
  13.5.3 PRODUCT PORTFOLIO
  13.5.4 RECENT DEVELOPMENTS
13.6 FRESENIUS SE & CO. KGAA
  13.6.1 COMPANY SNAPSHOT
  13.6.2 REVENUE ANALYSIS
  13.6.3 PRODUCT PORTFOLIO
  13.6.4 RECENT DEVELOPMENTS
13.7 EUROPE HEALTH PRODUCTS, INC.
  13.7.1 COMPANY SNAPSHOT
  13.7.2 PRODUCT PORTFOLIO
  13.7.3 RECENT DEVELOPMENT
13.8 HORMEL FOODS, LLC
  13.8.1 COMPANY SNAPSHOT
  13.8.2 GEOGRAPHICAL PRESENCE
  13.8.3 PRODUCT PORTFOLIO
  13.8.4 RECENT DEVELOPMENTS
13.9 MEAD JOHNSON & COMPANY, LLC.
  13.9.1 COMPANY SNAPSHOT
  13.9.2 GEOGRAPHICAL PRESENCE
  13.9.3 PRODUCT PORTFOLIO
  13.9.4 RECENT DEVELOPMENTS
13.10 MEDLINE INDUSTRIES, INC
  13.10.1 COMPANY SNAPSHOT
  13.10.2 GEOGRAPHICAL PRESENCE
  13.10.3 PRODUCT PORTFOLIO
  13.10.4 RECENT DEVELOPMENTS
13.11 MEDTRITION, INC.
  13.11.1 COMPANY SNAPSHOT
  13.11.2 PRODUCT PORTFOLIO
  13.11.3 NO RECENT DEVELOPMENTS
13.12 NUTRITIONAL MEDICINALS, LLC
  13.12.1 COMPANY SNAPSHOT
  13.12.2 GEOGRAPHICAL PRESENCE
  13.12.3 PRODUCT PORTFOLIO
  13.12.4 NO RECENT DEVELOPMENTS
13.13 REAL FOOD BLENDS
  13.13.1 COMPANY SNAPSHOT
  13.13.2 PRODUCT PORTFOLIO
  13.13.3 RECENT DEVELOPMENTS
13.14 VICTUS
  13.14.1 COMPANY SNAPSHOT
  13.14.2 PRODUCT PORTFOLIO
  13.14.3 RECENT DEVELOPMENTS

14 RELATED REPORTS

LIST OF TABLES

Table 1 EUROPE ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 2 EUROPE STANDARD FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, BY REGION, 2017-2026 (USD MILLION)
Table 3 EUROPE STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 4 EUROPE DISEASE SPECIFIC IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, BY REGION, 2017-2026 (USD MILLION)
Table 5 EUROPE DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 6 EUROPE ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 7 EUROPE CRITICAL CARE IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 8 EUROPE GASTROENTEROLOGY IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 9 EUROPE ONCOLOGY IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 10 EUROPE NEUROLOGY IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 11 EUROPE DIABETES IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 12 EUROPE OTHERS IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 13 EUROPE ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 14 EUROPE GASTRIC TUBE FEEDING IN ENTERAL FEEDING FORMULA MARKET, BY TUBE OF FEEDING, BY REGION, 2017-2026 (USD MILLION)
Table 15 EUROPE NASOGASTRIC TUBE FEEDING IN ENTERAL FEEDING FORMULA MARKET, BY TUBE OF FEEDING, BY REGION, 2017-2026 (USD MILLION)
Table 16 EUROPE GASTROSTOMY TUBE FEEDING IN ENTERAL FEEDING FORMULA MARKET, BY TUBE OF FEEDING, BY REGION, 2017-2026 (USD MILLION)
Table 17 EUROPE DUODENAL OR JEJUNAL TUBE FEEDING IN ENTERAL FEEDING FORMULA MARKET, BY TUBE OF FEEDING, BY REGION, 2017-2026 (USD MILLION)
Table 18 EUROPE ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 19 EUROPE ADULT IN ENTERAL FEEDING FORMULA MARKET, BY STAGE, BY REGION, 2017-2026 (USD MILLION)
Table 20 EUROPE PEDIATRIC IN ENTERAL FEEDING FORMULA MARKET, BY STAGE, BY REGION, 2017-2026 (USD MILLION)
Table 21 EUROPE ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 22 EUROPE HOSPITALS IN ENTERAL FEEDING FORMULA MARKET, BY END USER, BY REGION, 2017-2026 (USD MILLION)
Table 23 EUROPE LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 24 EUROPE LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, BY REGION, 2017-2026 (USD MILLION)
Table 25 EUROPE ENTERAL FEEDING FORMULA MARKET, BY COUNTRY, 2017-2026(USD MILLION)
Table 26 EUROPE ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 27 EUROPE STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 28 EUROPE DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 29 EUROPE ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 30 EUROPE ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 31 EUROPE ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 32 EUROPE ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 33 EUROPE LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 34 GERMANY ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 35 GERMANY STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 36 GERMANY DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 37 GERMANY ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 38 GERMANY ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 39 GERMANY ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 40 GERMANY ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 41 GERMANY LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 42 U.K. ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 43 U.K. STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 44 U.K. DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 45 U.K. ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 46 U.K. ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 47 U.K. ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 48 U.K. ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 49 U.K. LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 50 FRANCE ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 51 FRANCE STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 52 FRANCE DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 53 FRANCE ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 54 FRANCE ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 55 FRANCE ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 56 FRANCE ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 57 FRANCE LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 58 SPAIN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 59 SPAIN STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 60 SPAIN DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 61 SPAIN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 62 SPAIN ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 63 SPAIN ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 64 SPAIN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 65 SPAIN LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 66 ITALY ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 67 ITALY STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 68 ITALY DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 69 ITALY ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 70 ITALY ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 71 ITALY ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 72 ITALY ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 73 ITALY LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 74 SWITZERLAND ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 75 SWITZERLAND STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 76 SWITZERLAND DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 77 SWITZERLAND ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 78 SWITZERLAND ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 79 SWITZERLAND ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 80 SWITZERLAND ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 81 SWITZERLAND LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 82 NETHERLAND ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 83 NETHERLAND STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 84 NETHERLAND DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 85 NETHERLAND ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 86 NETHERLAND ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 87 NETHERLAND ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 88 NETHERLAND ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 89 NETHERLAND LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 90 NORWAY ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 91 NORWAY STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 92 NORWAY DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 93 NORWAY ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 94 NORWAY ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 95 NORWAY ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 96 NORWAY ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 97 NORWAY LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 98 BELGIUM ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 99 BELGIUM STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 100 BELGIUM DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 101 BELGIUM ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 102 BELGIUM ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 103 BELGIUM ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 104 BELGIUM ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 105 BELGIUM LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 106 RUSSIA ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 107 RUSSIA STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 108 RUSSIA DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 109 RUSSIA ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 110 RUSSIA ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 111 RUSSIA ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 112 RUSSIA ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 113 RUSSIA LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 114 POLAND ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 115 POLAND STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 116 POLAND DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 117 POLAND ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 118 POLAND ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 119 POLAND ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 120 POLAND ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 121 POLAND LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 122 TURKEY ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 123 TURKEY STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 124 TURKEY DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 125 TURKEY ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 126 TURKEY ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 127 TURKEY ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 128 TURKEY ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 129 TURKEY LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 130 REST OF EUROPE ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)

LIST OF FIGURES

Figure 1 EUROPE ENTERAL FEEDING FORMULA MARKET: SEGMENTATION
Figure 2 EUROPE ENTERAL FEEDING FORMULA MARKET: DATA TRIANGULATION
Figure 3 EUROPE ENTERAL FEEDING FORMULA MARKET: DROC ANALYSIS
Figure 4 EUROPE ENTERAL FEEDING FORMULA MARKET:BOTTOM UP APPROACH
Figure 5 EUROPE ENTERAL FEEDING FORMULA MARKET:TOP DOWN APPROACH
Figure 6 EUROPE ENTERAL FEEDING FORMULA MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 EUROPE ENTERAL FEEDING FORMULA MARKET: THE MARKET CHALLENGE MATRIX
Figure 8 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE ENTERAL FEEDING FORMULA MARKET
Figure 9 NUMBER OF PRETERM BIRTHS IN FEW COUNTRIES, 2018
Figure 10 TOTAL POPULATION OF AGES 65 AND ABOVE (% OF TOTAL) IN 2015 & 2016
Figure 11 HEALTH EXPENDITURE PER CAPITA IN PPP INTERNATIONAL
Figure 12 EUROPE ENTERAL FEEDING FORMULA MARKET: SEGMENTATION
Figure 13 MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET ARE RISING NUMBER OF PRETERM BIRTH, GROWING NUMBER OF CHRONIC DISEASES, GROWING BUSINESS EXPANSION FOR NUTRITIONAL SUPPLY AND GROWING NEED OF NUTRITIONAL CARE FOR GERIATRIC POPULATION EXPECTED TO DRIVE THE MRKET FOR EUROPE ENTERAL FEEDING FORMULA MARKET IN THE FORECAST PERIOD 2019 TO 2026
Figure 14 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ENTERAL FEEDING FORMULA MARKET IN 2019 & 2026
Figure 15 EUROPE ENTERAL FEEDING FORMULA MARKET: BY PRODUCT, 2018
Figure 16 EUROPE ENTERAL FEEDING FORMULA MARKET: BY APPLICATION, 2018
Figure 17 EUROPE ENTERAL FEEDING FORMULA MARKET: BY TYPE OF TUBE FEEDING, 2018
Figure 18 EUROPE ENTERAL FEEDING FORMULA MARKET: BY STAGE, 2018
Figure 19 EUROPE ENTERAL FEEDING FORMULA MARKET: BY END USER, 2018
Figure 20 EUROPE ENTERAL FEEDING FORMULA MARKET SNAPSHOT (2018)
Figure 21 EUROPE ENTERAL FEEDING FORMULA MARKET: BY GEOGRAPHY (2018)
Figure 22 EUROPE ENTERAL FEEDING FORMULA MARKET: BY GEOGRAPHY (2019)
Figure 23 EUROPE ENTERAL FEEDING FORMULA MARKET: BY COUNTRY (2018 & 2026)
Figure 24 EUROPE ENTERAL FEEDING FORMULA MARKET: BY PRODUCT(2019 - 2026)
Figure 25 EUROPE ENTERAL FEEDING FORMULA MARKET: COMPANY SHARE 2018 (%)


More Publications